Cronos Group (TSE:CRON) Shares Up 0.3% – Still a Buy?

Cronos Group Inc. (TSE:CRON) shares shot up 0.3% on Friday . The company traded as high as C$3.76 and last traded at C$3.76. 81,193 shares changed hands during trading, a decline of 60% from the average session volume of 200,658 shares. The stock had previously closed at C$3.75.

Cronos Group Price Performance

The company has a debt-to-equity ratio of 0.17, a quick ratio of 24.01 and a current ratio of 24.24. The company has a 50-day moving average of C$3.61 and a 200-day moving average of C$3.33. The stock has a market capitalization of C$1.44 billion, a price-to-earnings ratio of 34.18, a P/E/G ratio of 0.12 and a beta of 1.30.

Cronos Group (TSE:CRON) last announced its earnings results on Thursday, November 6th. The company reported C$0.07 EPS for the quarter. The firm had revenue of C$50.60 million for the quarter. Cronos Group had a negative return on equity of 4.40% and a negative net margin of 42.65%. As a group, equities research analysts expect that Cronos Group Inc. will post -0.26 earnings per share for the current fiscal year.

Cronos Group Company Profile

Cronos Group, headquartered in Toronto, Canada cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis to Poland and Germany. In addition, it has entered joint ventures in Israel, Colombia, and Australia to drive further international cultivation and distribution growth. In the U.S. the company directly sells hemp-derived CBD and has an option to acquire 10.5% of U.S.